ebook Munafa Stock Market Course + Intraday & FNO calls  

       

LLY announcements Eli Lilly And Company announcements and dividends declared USA

Eli Lilly And Company Complete list of announcements declared & dividend announcements by Eli Lilly And Company LLY

Eli Lilly And Company LLY listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Eli Lilly And Company LLY

After Mounjaro Jab, Eli Lilly plans weight loss pill launch in India
Eli Lilly plans to launch an oral weight loss drug, orforglipron, after Mounjaro's India success. Regulatory submissions are expected soon, with potential approvals by 2026. This pill targets a broader patient group than injectables. Studies show orforglip
Announcement as on 18 September 2025

Why Eli Lilly Stock Was a Winner Today
Key PointsThere's a chance that an investigational obesity drug late in its development stage could be fast-tracked for FDA approval.
Announcement as on 16 September 2025

Eli Lilly launches Mounjaro KwikPen for diabetes, obesity treatment in India
Eli Lilly has launched Mounjaro in KwikPen, a prefilled pen for weekly administration, in India to treat type 2 diabetes and obesity. Priced from Rs 14,000, it offers personalized treatment with six dose strengths. Mounjaro, a dual GIP and GLP-1 receptor a
Announcement as on 13 August 2025

Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?
For weight loss drug leaders, the last two weeks have been nothing short of disastrous for shares. Industry pioneer Novo Nordisk A/S (NYSE: NVO) saw its stock drop nearly 22% on July 29 after lowering its full-year guidance. Then, on Aug. 7, Eli Lilly (NYS
Announcement as on 08 August 2025

Eli Lilly stock is tumbling after trial data from oral weight-loss drug

Announcement as on 07 August 2025

Announcements by Eli Lilly And Company first page | Next page | Prev page |

LLY Eli Lilly And Company current price & indicator signals

Moving Averages for Eli Lilly And Company

  • 5Day Average: 909.2
  • 12Day Average: 919.06
  • 20Day Average: 920.71
  • 50Day Average: 963.4
  • 100Day Average: 1006.86
  • 150Day Average: 963.53
  • 200Day Average: 907.85

LLY Indicators & signals

Indicator MACD (12,26,9)

915.05, 929.53, -14.58
Indicator MACD is in negative zone

Indicator ADX (14)

33.68, 17.8, 35.88
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 54
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of LLY Eli Lilly And Company are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
24 Fri Apr 2026 883.96 871.73 to 917.06 -3.67% 1.08 times
23 Thu Apr 2026 917.65 911.89 to 930.00 -0.42% 0.9 times
22 Wed Apr 2026 921.48 902.23 to 922.54 2.04% 1.1 times
21 Tue Apr 2026 903.02 881.11 to 913.05 -1.83% 1.71 times
20 Mon Apr 2026 919.90 912.50 to 929.64 -0.77% 0.81 times
17 Fri Apr 2026 927.03 917.80 to 929.99 2.61% 1.37 times
16 Thu Apr 2026 903.43 898.15 to 920.00 -0.18% 0.56 times
15 Wed Apr 2026 905.03 888.03 to 930.00 -1.94% 1.78 times
14 Tue Apr 2026 922.89 915.04 to 939.93 -0.72% 0.52 times
13 Mon Apr 2026 929.55 927.17 to 945.90 -1.07% 0.88 times
10 Fri Apr 2026 939.57 935.54 to 963.94 -1.64% 0.37 times
09 Thu Apr 2026 955.19 939.29 to 963.76 0.2% 0.7 times

Videos related to: LLY announcements Eli Lilly And Company announcements and dividends declared USA

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

LLY announcements Eli Lilly And Company announcements and dividends declared USA

 

Back to top